logo

Enter Symbol

PAREXEL IN(NSDQ:PRXL)
Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.
# Employees: 9275
Address: 200 West Street,Waltham,MA,USA
Phone: 781 487-9900
Fax: 781-487-0525
Website: www.parexel.com
Email: jill.baker@parexel.com
Sector: Medical
Industry: MED-DRUGS
Executive Officers
Josef H. Von Rickenbach (Chmn.; C.E.O.)
James F. Winschel Jr. (Sr. V.P.; C.F.O.)
Dana A. Callow Jr. (Dir.)
Richard L. Love (Dir.)
Patrick J. Fortune (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 1/25/2010
Mean EPS (Next Qtr): $0.20
Mean EPS (Year): $0.91
Mean Estimate(Long Term): $14.40
P/E Ratio(Based on EPS estimate): 13.760
Number of Estimates: 10
Shares Performance
Period PRXL Compare to S&P
YTD 29.25 % 6.97 %
4 Weeks -11.81 % -12.76 %
12 Weeks -3.91 % -9.40 %
Shares Information
Analyst Coverage: Y
Avg Volume: 514371
Shares Outstanding: 57M
Market Cap: $0.73B
52 Week High: $16.54
52 Week Low: $6.57
P/E Ratio: 15.690
PEG Ratio: 0.960
Split: On 3/4/2008 PRXL split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 90.91 %
EPS Growth in Last Year: -8.70 %
Sales Growth in Last Quarter: 5.19 %
Sales Growth in Last Quarter: -3.76 %
Financials
Qtr Book Value: $1.66
Cash Flow/Share: $7.21
Change in Payout Ratio: 0.000
Price/Sales: 0.590
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia